Inducing such an expansion of B10 cells may be particularly therapeutic in autoimmune syndromes such as SLE where aberrant CD154 expression contributes to inflammation and the generation of pathogenic isotype-switched B cells. The gene discussed is CD40LG; the disease is systemic lupus erythematosus.